Press Release

______________________________________________________________________________________

Embargoed 1 PM ET                                                                                         Contact: CDC Media Relations

July 9, 2019                                                    July 9, 2019                                                                                                                                (404) 639-3286

 

CDC Urges Doctors to Rapidly Recognize and Report AFM Cases

Intense effort underway to understand and prevent this serious neurologic syndrome

As the late summer/early fall “season” for acute flaccid myelitis (AFM) nears, CDC is calling on medical professionals to quickly recognize AFM symptoms and report all suspected cases to their health department. Early recognition and reporting are critical for providing patients with appropriate care and rehabilitation, and better understanding AFM, according to a new Vital Signs report.

The majority of AFM patients are previously healthy children who had respiratory symptoms or fever consistent with a viral infection less than a week before they experienced limb weakness. Since AFM can progress quickly from limb weakness to respiratory failure requiring urgent medical intervention, rapidly identifying symptoms and hospitalizing patients are important.

Dr. Robert Redfield, CDC Director

_______________________________________________________

“Timing is key for responding to AFM and outbreaks. The quicker doctors recognize symptoms, collect specimens, and report suspected cases to health departments, the more insight we gain into this serious illness,” said CDC Director Robert Redfield, M.D. “AFM is a national public health priority. CDC is working with the AFM Task Force to strengthen the knowledge base about how viruses cause AFM, and best practices around patient treatment and rehabilitation.”

__________________________________________________________________________________________

Late summer and early fall is AFM “season”

CDC began tracking AFM in 2014, when the first outbreak of 120 cases occurred. Another outbreak occurred in 2016 with 149 cases, and again with 233 patients in 41 states in 2018– the largest outbreak so far. AFM cases have so far followed a seasonal and biennial pattern, spiking between August and October every other year.

In an analysis of cases confirmed in 2018, CDC detected enteroviruses and rhinoviruses in nearly half of respiratory and stool specimens. Of the 74 cases with a cerebral spinal fluid specimen, only two were positive for enteroviruses (EV-A71 and EV-D68). CDC and other scientists continue to investigate how enteroviruses, including EV-D68, might initiate AFM. All specimens tested negative for poliovirus, a related enterovirus that can cause AFM. 

Dr. Tom Clark, deputy director, Division of Viral Diseases

____________________________________

“Our thorough investigation of AFM will help lead to more answers about this severe disease,” said Tom Clark, M.D., M.P.H, deputy director, Division of Viral Diseases. “We are monitoring AFM trends and the clinical presentation, conducting research to identify possible risk factors, using advanced lab testing and research to understand how viral infections may lead to AFM, and tracking long-term outcomes of AFM patients.”

_________________________________________________________________________________________  

CDC, with experts from the National Institutes of Health, academia, health departments, and parent advocacy groups, is committed to increasing awareness of AFM, and moving national priorities forward to advance our understanding of AFM and its prevention, treatment, and outcomes.

To read more about the Nationwide Outbreak of Acute Flaccid Myelitis—United States, 2018 and the entire Vital Signs report, visit www.cdc.gov/vitalsigns.

About Vital Signs

Vital Signs is a report that appears as part of the CDC’s Morbidity and Mortality Weekly Report. Vital Signs provides the latest data and information on key health indicators.

 

###

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

 

 

 

//IDSA / HIVMA /PIDS logos//

NEWS RELEASE
June 24, 2019

Physicians, Health Providers and Researchers Call on Presidential Candidates to Back Funding, Preparedness and Evidence-based Responses to Infectious Diseases, HIV

Contact IDSA: Jennifer Morales This email address is being protected from spambots. You need JavaScript enabled to view it. (703) 299-0412 PCI Public Relations (312) 558-1770  This email address is being protected from spambots. You need JavaScript enabled to view it.

In a bipartisan-aimed petition, more than 500 members of the Infectious Diseases Society of America, its HIV Medicine Association and the Pediatric Infectious Diseases Society are calling on all presidential candidates to commit themselves to public health policies, programs, and investments necessary to protect the lives and health of Americans and reduce the impact of infectious diseases globally, including from the threats of growing and emerging infectious diseases, vaccine preventable diseases, infections increasingly resistant to existing treatments, as well as from the impacts of climate change.

Urging strong stances, support and funding for public health measures against leading domestic and global health challenges, the signers urge White House aspirants to articulate their priorities for tackling infectious diseases opportunities and threats, including with interventions to:

  • Increase vaccine access and uptake;
  • Strengthen responses to the opioid crisis and associated infectious disease impacts;
  • Build antibiotic stewardship, research and development;
  • Sustain U.S. leadership of global HIV and TB responses, while enhancing global health security efforts;
  • Expand interventions to reverse increased rates of sexually transmitted diseases;
  • Use existing tools to end the HIV epidemic and eliminate hepatitis C virus in America;
  • Confront climate change;
  • And build the infectious diseases and HIV trained health workforce necessary to meet these challenges.

The full petition, with further information on infectious diseases priorities and actions, is here.

###


 
 
Record Number of Abstracts Submitted to 2019 Antimicrobial Stewardship Conference - St. Louis, MO
 

During this year's Antimicrobial Sterwardship Conference, We had a record number of participants (220) and abstracts (77) this year. Leading experts from around the country discussed important antimicrobial stewardship topics including Gram-negative resistance (Latania Logan MD), stewardship for the pediatric intensive care unit (Kathleen Chiotos MD) and communication insights for stewards (Julia Szymczak, PhD). The three Pediatric ID ASP Fellow award winners (Rebecca Same, MD, Sophie Katz, MD and Maria Equiguren Jimenez, MD) presented their outstanding research.   Two ASP conference attendees had the following to say about the 2019 conference:

"This was my first time attending this conference.  I absolutely loved it. It was for two days so not too long. Lectures were all pediatric relevant and in line with ASP priorities.  Networking with colleagues in other places is invaluable. Will surely go back next year!"  ~ Dr. Upadhyayula
 
"The PIDS ASP conference was a fantastic opportunity to talk to other stewards about their programs and research and discuss some of the obstacles that we face at my home institution. I came away from the conference with multiple ideas for our program from small tweaks to larger policy goals." ~ Dr. TeKippe
 

SAVE THE DATE for next year on May 28th and 29th for the 11th annual International Pediatric ASP meeting.

   
 

Please be aware that www.idweek.org is the only official site for registering for IDWeek 2019. Experient is the official housing provider for IDWeek 2019 and their site can only be accessed through www.idweek.org. International groups can also use www.idweekinternational.com for housing and travel assistance.

Fraudulent websites have been reported, so it is critical that you use only the official IDWeek websites mentioned above to register for the meeting and for booking a hotel reservation through IDWeek. We do not ask for member identification numbers during registration, and no one will email you to ask for your membership password. Please do not provide this information if requested, and be aware that you are using an illegitimate website.

IDWeek cannot guarantee your registration or housing if you purchase using an illegitimate website.
 

IDWeek staff make every effort to shut down illegitimate websites as soon as we are made aware of them; however, new attempts to create fraudulent sites occur regularly. If you are concerned about your registration, please contact IDWeek staff at This email address is being protected from spambots. You need JavaScript enabled to view it..

Dear Colleagues:

 

We are in the midst of an upsurge in measles in the US, thanks largely to the dedicated misinformation efforts of the anti-vaccine movement. I wonder if we could learn from the history of polio vaccination as we try to fight the rise in vaccine hesitancy in this country. A little local history from here in Cincinnati might help. On April 24, 1960, Albert Sabin participated in the initial rollout of the oral polio vaccine he had developed at Cincinnati Children’s Hospital on the first “Sabin Sunday.” He was surprised at the huge lines of parents bringing their children in for his vaccine, and by the end of the day more than 20,000 local children had received the vaccine. Vaccine uptake eventually became so universal that polio was eradicated from the Western hemisphere and from most of the world. What is different now? I think one major factor is that severe disease from measles does not seem real to most Americans, and very few have seen it affect themselves or their neighbors. In the case of polio, there was great fear of the crippling effects that could result from the infection, and this fear plus perhaps a healthy respect for science led to enthusiastic vaccine uptake. It seems that right now our communities could use a healthy dose of fear of the infectious diseases that our vaccines can now prevent, along with real education about vaccine safety to counteract misinformation from the anti-vaxxers. One of our key missions at PIDS is to promote vaccine uptake in order to save the lives of children, and as a society we stand firmly against non-medical vaccine exemptions. Let’s help think of ways to also educate our communities about the seriousness of vaccine-preventable diseases, as we seek always to build trust in the safety and efficacy of vaccines.

 

Peace,     

Dr. Paul Spearman

PIDS Board President

Dear Provider,

Due to the current increase in measles cases in the United States (https://www.cdc.gov/mmwr/volumes/68/wr/mm6817e1.htm), the Centers for Disease Control and Prevention has developed the following summary for vaccination of adults against measles with measles, mumps, rubella (MMR) vaccine. Recommendations for vaccination and assessing immunity in adults have not changed since publication of the Advisory Committee on Immunization Practices (ACIP) recommendations for the Prevention of Measles, Rubella, Congenital Rubella syndrome, and Mumps in June 2013. (https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6204a1.htm)

WHAT ADULT PROVIDERS NEED TO KNOW:

Providers do not need to actively screen adult patients for measles immunity.  This is because of high population immunity and low risk of disease among adults in non-outbreak areas in the U.S.

Providers should make sure patients have measles protection before international travel.  U.S. residents traveling internationally are at high risk for acquiring measles abroad.  They can also transmit measles to susceptible persons, such as infants, when they return home.

If a patient is traveling internationally and measles immunity is unknown, providers should vaccinate, unless there are contraindications.  Serologic testing for measles immunity is not recommended.

During outbreaks, providers should consult with local health departments for the most up-to-date recommendations for their community.  This may include additional doses of MMR for your patients.  

To download and print this letter in its entirety, click here.

            The Social Media Working Group is an ad hoc taskforce working under the auspices of the Communications Committee, focused on delivering a vibrant, engaging, and educational presence for PIDS on a variety of social media. The goals of our group are to help develop a cohesive and impactful communications portfolio, and then deliver this messaging to our membership, as well as non-member interested parties and international colleagues, through Twitter, Facebook, and LinkedIn.

            Most members who are “Twitter-active” will have likely seen our work on our Twitter feed, which is our most active social media account, and where we receive the most traffic. However, we also encourage you to look into our Facebook page, where we post live feeds from conferences, including most recently the St Jude/PIDS conference in Memphis, as well as our LinkedIn account.

            We seek to keep our membership and the broader community apprised of important awareness events, such as World Immunization Week, World AIDS Day, and others, as well as new and interesting news and journal articles in pediatric infectious diseases. We also seek to advocate for core PIDS priorities, in particular vaccines and health promotion. We work closely with our colleagues at the social media accounts of the Journal of the Pediatric Infectious Diseases Society (JPIDS), our society’s flagship publication.

            In the coming months, look out for some planned “tweet-storms” around important events, in particular ID Week in October, as well as some Twitter and Facebook Q&A “Meet the Professor” sessions. If you have an interest in all of this, and would like to impact the work that PIDS does on advocating on #SoMe (social media!), please reach out to any member of our working group. We are always looking for new and enthusiastic members!

For the Social Media Working Group (SMWG) –

Kevin O’Callaghan (Social Media Editor – PIDS)

Saul Hymes (JPIDS Social Media Editor)

JB Cantey

Michael Chang

Ozlem Equils

Christina Gagliardo

Rana Hamdy

Claudette Poole

Caroline Reuter

Diana Yu

Want to stay up to date with hot topics published in Pediatric Infectious Diseases?

The Australasian Society for Infectious Diseases (ANZPID) has an open-access Journal Club and Quiz Club that posts monthly. Articles of interest are appraised by ANZPID members, as well as members of other international Pediatric Infectious Diseases societies, including PIDS. The focus of this Journal Club is to highlight practice-changing literature in our field. At the end of each appraisal, there is brief Q&A relating to the article's findings. This is an excellent educational resource from trainees to faculty! PIDS contributes to this Journal Club twice a year. This is a great opportunity particularly for trainees, as the appraisal can be considered for a "Heads Up" publication in the Journal of Paediatric and Child Health journal. The link to the ANZPID journal club site is: https://www.asid.net.au/groups/paediatric-id-journal-and-quiz-club  From here you can navigate to 2019, or back through prior years.

If you have any questions or are interested in submitting an appraisal on behalf of PIDS, please contact Rosey Olivero at This email address is being protected from spambots. You need JavaScript enabled to view it..

National Infant Immunization Week (NIIW) is an annual observance to highlight the importance of protecting infants from vaccine-preventable diseases and to celebrate the achievements of immunization programs in promoting healthy communities throughout the United States. This year, NIIW will be April 27-May 4, 2019.

  • In 2019, we are celebrating the 25th anniversary of NIIW. When the NIIW observance was established in 1994, immunization programs were facing significant challenges. The nation was in the midst of a serious measles outbreak and communities across the U.S. were seeing decreasing immunization rates among children.

Vaccines are among the most successful and cost-effective public health tools available for preventing disease and death. They not only help protect vaccinated individuals, but also help protect entire communities by preventing and reducing the spread of infectious diseases. Among children born during 1994-2018, vaccination will prevent an estimated 419 million illnesses, 26.8 million hospitalizations, and 936,000 deaths over the course of their lifetimes.

NIIW provided an opportunity to draw attention to these issues and to focus on solutions. Communities have continued to use the week each year to raise awareness about the importance of ensuring all children are fully protected from vaccine preventable diseases through vaccination. Today, many immunization programs, partners and communities can celebrate high infant vaccination rates.

For more information on NIIW, please visit:  www.cdc.gov/vaccines/niiw

By Janet R. Gilsdorf, MD, Chair

The PIDS Nominations and Awards Committee is seeking nominees for President-Elect, Secretary-Treasurer, two (2) Directors, and three (3) members for the Nominations and Awards Committee. In order to recruit the most qualified individuals to serve, the committee needs your input. Members of the Society may self-nominate or identify a colleague who is willing to be considered for nomination. Below are the desired leadership qualifications and the commitment of time necessary for each position.
 
Qualifications:

  • Demonstrated commitment to PIDS (e.g., committee work) and the pediatric infectious diseases community
  • Interest in shaping PIDS’ direction, philosophy and policies
  • Strong background in committee and volunteer work
  • Effective skills in communication, listening, organization, and planning
  • Ability to identify and solve problems
  • Willingness to express or entertain diverse perspectives
  • Respect and recognition by peers in the infectious diseases community
  • Willingness to commit the time required to actively participate in PIDS activities

President-Elect (two-year term):

The President-Elect attends two Board meetings per year (held in conjunction with the PIDS/St. Jude Meeting and IDWeek); serves as a member of the Executive Committee and participates on quarterly conference calls; participates in strategic planning for the Society; and performs the duties and powers of the President in his/her absence or in the event of death, or inability to act. The President-Elect also serves as the vice chair of the PIDS Foundation.

Secretary-Treasurer (two-year term):

The Secretary-Treasurer attends two Board meetings per year (held in conjunction with the PIDS/St. Jude Meeting and IDWeek); serves as a member of the Executive Committee and participates on quarterly conference calls; participates in strategic planning for the Society; anticipates and brings to the Board of Directors potential changes in operation, finance, governance, committee structure and bylaws that would better serve the Society's goals; and performs the duties and powers of the President and President-Elect in their absence or in the event of death or inability to act until Board arranges an election to fill the vacancy.

PIDS Board of Directors Member-At-Large: (four-year term). A Member-At-Large attends two Board meetings per year (held in conjunction with the PIDS/St. Jude Meeting and IDWeek); participates in strategic planning for the Society; participates in ad hoc conference calls and votes; anticipates assuming chairmanship and/or membership of one or more PIDS committees.
 
Nominations Committee Member: (two-year term). Committee member participates in two-three conference calls a year to select a slate for that year’s officers, directors, Nominations and Awards Committee, and awards; participates in invigorating the process of recognition of colleagues; helps write biographical sketches of awardees for announcement and publication.
 
Click here to submit a nomination. The deadline to submit nominations is Wednesday, May 29th. Once you have submitted your nomination, please forward a brief biographical sketch or curriculum vitae and a statement outlining prior participation in PIDS activities to Christy Phillips via e-mail (This email address is being protected from spambots. You need JavaScript enabled to view it.).

Innovative Tool Offers Expert Guidance to Help Prevent Infections in Children

A new comprehensive resource provides practical, expert guidance for the urgent fight against healthcare-associated infections in children across a wide range of medical settings. Available to pre-order now, the Handbook of Pediatric Infection Prevention and Control fills an important gap in the healthcare field by addressing the nuances and challenges specific to preventing infections in children, from the clinic to the intensive care unit and beyond.

“Children are not just tiny adults, and this impacts many aspects of their medical care, including infection prevention,” said handbook co-editor Kristina A. Bryant, MD, professor of pediatrics in the Division of Pediatric Infectious Diseases at the University of Louisville and the healthcare epidemiologist at Norton Children’s Hospital. “This book offers practical guidance and solutions for the unique infection prevention challenges that providers encounter in pediatric settings on a daily basis.”

Developed by the Pediatric Infectious Diseases Society, the world’s largest organization focused on the treatment, control, and eradication of infectious diseases that affect children, the handbook addresses various infections and related issues across the spectrum of healthcare settings, from acute care hospitals and ambulatory practices to long-term care facilities. Covered topics include respiratory pathogens, surgical site infections, multidrug-resistant organisms, C. difficile, norovirus, device-associated infections, and antimicrobial stewardship, among many others.

Written by noted experts in the field, each chapter opens with a real-world clinical scenario, followed by frequently raised questions. Links to evidence-based guidelines are provided where available, in addition to expert guidance in areas where guidelines do not currently exist. Sample policies for institutions, algorithms, and educational tools are also included in the Handbook of Pediatric Infection Prevention and Control, which is published by Oxford University Press. The book’s co-editors also wish to offer their sincere thanks to the Pediatric Leadership Council steering committee of the Society for Healthcare Epidemiology of America (SHEA) for its many contributions. SHEA has helped define best practices in healthcare epidemiology and infection prevention worldwide since its founding in 1980.

“We hope this book fills an important need,” said handbook co-editor Judith A. Guzman-Cottrill, DO, professor of pediatrics in the Division of Infectious Diseases at Oregon Health & Science University. “We sought to create an essential resource for infection preventionists, healthcare epidemiologists, infectious disease fellows, and anyone who provides support for infection prevention programs in pediatric facilities.”

###

The Pediatric Infectious Diseases Society (PIDS) is the world’s largest professional organization of experts in the care and prevention of infectious diseases in children. PIDS membership includes leaders in clinical care, public health, academia, government, and industry who advocate for the improved health of children nationally and globally. The Society fulfills its mission through research, advocacy, guideline development, fellowship training, continuing medical education, its support of immunization practices in children, and the Journal of the Pediatric Infectious Diseases Society, its peer-reviewed publication, which recently received its first Impact Factor. To learn more about PIDS, visit www.pids.org and follow PIDS on Facebook and Twitter.

 

Our 8-person committee oversees and coordinates communications within PIDS, between PIDS and other organizations with shared missions, and between PIDS and the public. We also evaluate marketing materials, as well as other potential communication vehicles, in meeting the needs of the membership and develop recommendations for future means of communication. Some of our specific efforts include collating job postings and collaboration on the bimonthly publication PIDSNews. Our 11-person Social Media Working Group, led by Kevin O’Callaghan, works to utilize social media to highlight PIDS activities and publications in JPIDS.

We also want to highlight one of our new initiatives – engaging Society membership with PIDS Connect. If you’re not yet familiar with PIDS Connect, this discussion board is exclusively for PIDS members and is a great place to share information with colleagues or get input on complex clinical questions. Our committee members will be regularly posting thought-provoking questions and information on hot topics in our field. We invite you all to connect with us. 

 

JOINT NEWS RELEASE
March 22. 2019

The Kentucky governor’s decision this week to voice support for the irresponsible practice of deliberately exposing children to chickenpox as an alternative to vaccination is gravely concerning. The stance that Gov. Bevin defended, of a student filing suit against the Kentucky health department’s vaccination requirements, highlights urgent needs for public education on the value of medical immunizations, and for policies allowing exemptions only on the basis of medical contraindications. Events in recent weeks also demonstrate consequences of vaccine avoidance, as a mumps outbreak at Temple University in Pennsylvania continues to spread, prompting the offer of free immunizations there. And, as six U.S. health departments battle ongoing measles outbreaks that put our country on a course to exceed last year’s case count of a deadly and preventable disease, recognition that vaccines are among the most important public health tools we have remains essential.

The members of the PIDS Education Committee are pleased to provide this update to the PIDS membership about our activities. There is depth of leadership and experience on the PIDS Education Committee, now 25 members strong. The 3 main aims of the Committee are to 1) engage with colleagues in partner societies to develop and promote educational programs and services for our membership; 2) develop educational materials that advance clinical care; and 3) consider strategies to bring ID education to the broader community.

Negotiating a start-up package can be an intimidating part of finding a new job. Drs. Betsy Herold and Natasha Halasa helped demystify the process during a panel at the 18th Annual St. Jude/PIDS Pediatric Infectious Disease Research Conference (Watch the video on Facebook @PIDSociety). They advised framing your start-up package request as the plan for the next 3-5 years of your career, including your goals and what you need to meet those goals.

The Pediatric Infectious Diseases Society (PIDS), whose membership constitutes individuals dedicated to the treatment, control, and eradication of infectious diseases in children, opposes legislation or regulations that would allow children to be exempted from school and childcare immunization requirements based on their parents’ personal or religious beliefs (non-medical exemptions). Exemptions from school and childcare requirements can lead to outbreaks of disease.